| British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults CA Lamb, NA Kennedy, T Raine, PA Hendy, PJ Smith, JK Limdi, ... Gut 68 (Suppl 3), s1-s106, 2019 | 2093 | 2019 |
| Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study NA Kennedy, GA Heap, HD Green, B Hamilton, C Bewshea, GJ Walker, ... The lancet Gastroenterology & hepatology 4 (5), 341-353, 2019 | 613 | 2019 |
| The second European evidenced-based consensus on reproduction and pregnancy in inflammatory bowel disease CJ Van der Woude, S Ardizzone, MB Bengtson, G Fiorino, G Fraser, ... Journal of Crohn's and Colitis 9 (2), 107-124, 2015 | 537 | 2015 |
| HLA-DQA1* 05 carriage associated with development of anti-drug antibodies to infliximab and adalimumab in patients with Crohn’s disease A Sazonovs, NA Kennedy, L Moutsianas, GA Heap, DL Rice, M Reppell, ... Gastroenterology 158 (1), 189-199, 2020 | 323 | 2020 |
| British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic NA Kennedy, GR Jones, CA Lamb, R Appleby, I Arnott, RM Beattie, ... Gut 69 (6), 984-990, 2020 | 293 | 2020 |
| Inflammatory bowel disease and pregnancy: lack of knowledge is associated with negative views CP Selinger, J Eaden, W Selby, DB Jones, P Katelaris, G Chapman, ... Journal of Crohn's and Colitis 7 (6), e206-e213, 2013 | 212 | 2013 |
| Gastric antral vascular ectasia (GAVE): an update on clinical presentation, pathophysiology and treatment CP Selinger, YS Ang Digestion 77 (2), 131-137, 2008 | 199 | 2008 |
| Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab NA Kennedy, JR Goodhand, C Bewshea, R Nice, D Chee, S Lin, ... Gut 70 (5), 865-875, 2021 | 183 | 2021 |
| Risankizumab in patients with moderate to severe Crohn's disease: an open-label extension study BG Feagan, J Panés, M Ferrante, A Kaser, GR D'Haens, WJ Sandborn, ... The Lancet Gastroenterology & Hepatology 3 (10), 671-680, 2018 | 170 | 2018 |
| Medication adherence in inflammatory bowel disease W Chan, A Chen, D Tiao, C Selinger, R Leong Intestinal Research 15 (4), 434-445, 2017 | 156 | 2017 |
| Efficacy of soluble fibre, antispasmodic drugs, and gut–brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis CJ Black, Y Yuan, CP Selinger, M Camilleri, EMM Quigley, P Moayyedi, ... The lancet Gastroenterology & hepatology 5 (2), 117-131, 2020 | 147 | 2020 |
| Inflammatory bowel disease and anxiety: links, risks, and challenges faced AS Bannaga, CP Selinger Clinical and experimental gastroenterology, 111-117, 2015 | 141 | 2015 |
| European Crohn’s and colitis guidelines on sexuality, fertility, pregnancy, and lactation J Torres, M Chaparro, M Julsgaard, K Katsanos, Z Zelinkova, M Agrawal, ... Journal of Crohn's and Colitis 17 (1), 1-27, 2023 | 136 | 2023 |
| Modifiable factors associated with nonadherence to maintenance medication for inflammatory bowel disease CP Selinger, J Eaden, DB Jones, P Katelaris, G Chapman, C McDonald, ... Inflammatory bowel diseases 19 (10), 2199-2206, 2013 | 129 | 2013 |
| SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group … JL Alexander, GW Moran, DR Gaya, T Raine, A Hart, NA Kennedy, ... The Lancet Gastroenterology & Hepatology 6 (3), 218-224, 2021 | 126 | 2021 |
| Patients' knowledge of pregnancy‐related issues in inflammatory bowel disease and validation of a novel assessment tool (‘CCPKnow’) CP Selinger, J Eaden, W Selby, DB Jones, P Katelaris, G Chapman, ... Alimentary pharmacology & therapeutics 36 (1), 57-63, 2012 | 117 | 2012 |
| Smoking prevalence and its influence on disease course and surgery in Crohn's disease and ulcerative colitis PC Lunney, VC Kariyawasam, RR Wang, KL Middleton, T Huang, ... Alimentary pharmacology & therapeutics 42 (1), 61-70, 2015 | 116 | 2015 |
| Long-term follow-up reveals low incidence of colorectal cancer, but frequent need for resection, among Australian patients with inflammatory bowel disease CP Selinger, JM Andrews, A Titman, I Norton, DB Jones, C McDonald, ... Clinical Gastroenterology and Hepatology 12 (4), 644-650, 2014 | 109 | 2014 |
| Probiotic VSL# 3 prevents antibiotic-associated diarrhoea in a double-blind, randomized, placebo-controlled clinical trial CP Selinger, A Bell, A Cairns, M Lockett, S Sebastian, N Haslam Journal of Hospital Infection 84 (2), 159-165, 2013 | 108 | 2013 |
| What factors might drive voluntary childlessness (VC) in women with IBD? Does IBD-specific pregnancy-related knowledge matter? CP Selinger, J Ghorayeb, A Madill Journal of Crohn's and Colitis 10 (10), 1151-1158, 2016 | 106 | 2016 |
Rupert W Leong (R W Leong)University of Sydney, Concord Repatriation Hospital在 sydney.edu.au 的电子邮件经过验证
